Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03791320 · ClinicalTrials.gov registry record
Fast Assessment of STenosis Severity- FASTII Study
A clinical trial, sponsored by Erasmus Medical Center.
- Completed
- Registry status
- 330
- Enrollment target
NCT03791320: Completed study, sponsored by Erasmus Medical Center.
NCT03791320 is a clinical trial that has completed, run by Erasmus Medical Center. The registered enrollment target is 330 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03791320 has completed, sponsored by Erasmus Medical Center.
- COMPLETED
- Registry status
- 330 participants
- Enrollment target
Study Summary
The Multicenter FAST (Fast Assessment of STenosis severity) study is a prospective observational multicenter study designed to evaluate the diagnostic accuracy of offline 3D-QCA based FFR, using CAAS Workstation (Pie Medical Imaging, Maastricht, the Netherlands) in identifying hemodynamically significant coronary artery disease with pressure wire-based FFR (≤0.80) as the reference standard.
Primary Outcome
The diagnostic accuracy of offline vFFR assessed by a blinded independent core laboratory to identify hemodynamically-significant coronary stenosis with FFR (≤0.8 or \>0.8) as the reference standard.
Interventions
- DIAGNOSTIC_TEST Vessel Fractional Flow Reserve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2018-10-15 |
| Est. Completion | 2019-11-01 |
What the finished NCT03791320 record still lists
NCT03791320 is an observational study that tracks outcomes without assigning an intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Vessel Fractional Flow Reserve is the first listed.
NCT03791320 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03791320 about?
NCT03791320 is a clinical study titled "Fast Assessment of STenosis Severity- FASTII Study". The Multicenter FAST (Fast Assessment of STenosis severity) study is a prospective observational multicenter study designed to evaluate the diagnostic accuracy of offline 3D-QCA based FFR, using CAAS Workstation (Pie Medical Imaging, Maastricht, the Netherlands) in identifying hemodynamically signif...
What is the current status of trial NCT03791320?
This trial is currently completed. The enrollment target is 330 participants. The study started on 2018-10-15. Estimated completion is 2019-11-01.
What interventions are being tested in trial NCT03791320?
The interventions under investigation include: Vessel Fractional Flow Reserve (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03791320?
This trial is sponsored by Erasmus Medical Center, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
- NCT03932773 · 330 participants · NA
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI